DroneShield has completed a one-off sale of its RfOne MKII long-range and high-frequency (HF) direction sensors to the Australian Army.
The long-range sensors will enable the service to evaluate and establish the requirements and options for its future counter-drone operations.
The Sydney-based firm did not disclose the quantity details nor the order value. The company noted that the sale includes a small procurement of equipment similar to its earlier standard purchases with other customers.
Meanwhile, DroneShield expects the sale is to give rise to a larger number of procurement orders for the system.
DroneShield CEO Oleg Vornik said: “As an Australian company, DroneShield is immensely proud to support the Australian Army with its long-range counter-drone strategy.”
Designed to deliver accurate detection and direction-finding capability for large sites, RfOne MKII is a stationary RF detection sand tracking system.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below formBy GlobalData
According to the company, deploying multiple RfOne MKII sensors across various installations enables triangulation to precisely position an uncrewed aerial vehicle or drone threat.
The RfOne MKII finder leverages the DroneShield proprietary detection database, which is updated based on subscription.
Some of the features of the system are military-grade connectors, networkable and scalable. It allows the integration of four sensors to provide 360° coverage.
In January last year, DroneShield’s US subsidiary announced its advancement from the US Army’s Phase II Expeditionary Technology Search (xTechSearch) programme to Phase III.